Pages that link to "Q40552138"
Jump to navigation
Jump to search
The following pages link to Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice (Q40552138):
Displaying 50 items.
- Flavivirus NS1: a multifaceted enigmatic viral protein (Q26247192) (← links)
- Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification (Q27315772) (← links)
- Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms (Q27472823) (← links)
- Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis (Q27477646) (← links)
- Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc- Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells (Q27481025) (← links)
- Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses (Q27481420) (← links)
- Vaccines and immunization strategies for dengue prevention (Q28077521) (← links)
- Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells (Q31110897) (← links)
- Infant mouse brain passaged Dengue serotype 2 virus induces non-neurological disease with inflammatory spleen collapse in AG129 mice after splenic adaptation (Q33405416) (← links)
- Current progress in dengue vaccines (Q33408300) (← links)
- Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. (Q33414156) (← links)
- Immune correlates for dengue vaccine development (Q33924674) (← links)
- Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. (Q34300986) (← links)
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge (Q34855420) (← links)
- Viral immune evasion in dengue: toward evidence-based revisions of clinical practice guidelines (Q35033144) (← links)
- Recent advancement in flavivirus vaccine development (Q35728621) (← links)
- Cooperation between CD4 T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen (Q35864468) (← links)
- Dengue vaccine: priorities and progress (Q35964754) (← links)
- Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model (Q36156558) (← links)
- Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. (Q36276476) (← links)
- Evaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine-loaded microspheres against dengue 2 virus (Q37120632) (← links)
- Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine (Q37500519) (← links)
- Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague (Q37588454) (← links)
- Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle (Q37698942) (← links)
- Immune Response to Dengue Virus and Prospects for a Vaccine (Q37827145) (← links)
- Next generation dengue vaccines: a review of candidates in preclinical development (Q37904025) (← links)
- The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker (Q38092510) (← links)
- The dengue virus non-structural 1 protein: risks and benefits (Q38179175) (← links)
- New insights into the immunopathology and control of dengue virus infection (Q38646923) (← links)
- Dengue Virus NS1 Protein Modulates Cellular Energy Metabolism by Increasing Glyceraldehyde-3-Phosphate Dehydrogenase Activity (Q38834797) (← links)
- Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection (Q40039016) (← links)
- Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation (Q40067512) (← links)
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity (Q40140011) (← links)
- A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates (Q40255696) (← links)
- Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. (Q40302309) (← links)
- A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection (Q40342245) (← links)
- Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection (Q40342715) (← links)
- DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. (Q40468297) (← links)
- Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge. (Q40477347) (← links)
- Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses. (Q40481579) (← links)
- DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus (Q40499543) (← links)
- Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence (Q40500253) (← links)
- Dengue infection. (Q42996339) (← links)
- Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein (Q56000963) (← links)
- A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein (Q56341869) (← links)
- Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate (Q56396121) (← links)
- Zika Virus Vaccines: Challenges and Perspectives (Q58742686) (← links)
- The Dual Role of the Antibody Response Against the Flavivirus Non-structural Protein 1 (NS1) in Protection and Immuno-Pathogenesis (Q66679100) (← links)
- The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection (Q83817670) (← links)
- Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2 (Q90191922) (← links)